#Healthcare Conference #Field Medical #PFA Platform

Field Medical Inc. Showcases Innovative Technology at J.P. Morgan Healthcare Conference

Field Medical Inc., a pioneering medical technology company, will be presenting at the 44th annual J.P. Morgan Healthcare Conference on January 15, 2026. This event, a prestigious gathering of healthcare leaders and investors, serves as a platform where the company's founder, Dr. Steven Mickelsen, will unveil its innovative next-generation pulsed field ablation (PFA) system designed for cardiac treatments.

The Future of Cardiac Treatment

Field Medical is focused on developing advanced solutions for complex cardiac rhythm disorders. Their flagship product, the FieldForce™ Ablation System, integrates cutting-edge technology to create transmural lesions, which are essential in treating conditions like ventricular tachycardia (VT) and atrial fibrillation (AF). Dr. Mickelsen's presentation will provide insights into the company’s clinical advancements and outline the ongoing Field-PULSE AF study, along with plans for a forthcoming regulatory approval study for VT.

With the FieldForce™ system, which utilizes the patented FieldBending™ energy, the company aims to enhance the efficacy and precision of cardiac ablation procedures. This innovative approach reflects a significant shift in how medical professionals can treat arrhythmias, thereby improving patient outcomes and reducing recovery times.

Key Highlights of the Presentation

During the conference, attendees will have the opportunity to explore:

- An overview of the FieldForce™ PFA platform and its distinctive features.
- Recent clinical findings that showcase the technology's effectiveness in treating VT and AF.
- Future plans and strategies for FDA approval, marking a significant milestone in the company’s journey.

For those interested in a more direct dialogue, the leadership team of Field Medical will be available for discussions during the event. Interested parties can schedule a meeting by reaching out via email.